Ahlcon since its inception has been putting untiring efforts to achieve Global recognition has a reliable manufacturer of Life Saving Drugs.
Convergence of likes and preferences of customers is taking place in the whole world and any company, even though it is addressing the needs of local consumers, has to adopt a global vision.
Taking clue from the above fact Ahlcon has set very ambitious and strict targets for itself.
Keeping in mind the recent changes in guidelines and amendments in schedule 'M' of drug and cosmetic act of India, Ahlcon has upgraded its quality system redesigned basic engineering to confirm the M.C.A standards. We are targeting to achieve "
WHO-International" , MCA -UK and US-FDA certifications by the end of 2003. This will help in reinforcing the confidence of our customers in our product quality as well as it will help us in finding the market for our products in the countries with stringent regulatory requirements.
To be a successful organization any firm has to build its own knowledge base and improvise on its core competencies. Ahlcon will have its own product development and research division by Apr.'2003. This division will have a dedicated team of best talent available to design and formulate new products for the company and the betterment of mankind. Ahlcon has decided to invest at least 5% of its revenue in the R&D from FY 2003 onwards, which is even better than many established Pharma companies in India. Ahlcon wants to see India on the top of the map in product innovations.
"He who
has health, has hope; He who has hope, has
everything."
Future
Plans
